An ecosystem refers to all living and nonliving features of a particular physical location. This includes living organisms as well as non living things, like weather, that interact with one another.
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
In this webinar, learn how Sanofi is building an integrated wet and digital lab environment to accelerate large molecule research. Yves Fomekong Nanfack, Executive Director and Head of End-t...
Does regulated laboratory software use in a modern software ecosystem have to be complex? Join us for our latest webinar to unlock insights into the intricacies of regulated laboratory softw...
The study of psychopathology is changing with the advent and pervasive use of smartphones, wearables, and connected devices together with significant advances in brain imaging. These new ave...
Join our webinar where we will highlight key features of the NovaSeq™ X series including technology innovations, product updates, and features of the on-board DRAGEN™ secondary a...
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
In this webinar, learn how Sanofi is building an integrated wet and digital lab environment to accelerate large molecule research. Yves Fomekong Nanfack, Executive Director and Head of End-t...
Does regulated laboratory software use in a modern software ecosystem have to be complex? Join us for our latest webinar to unlock insights into the intricacies of regulated laboratory softw...
The study of psychopathology is changing with the advent and pervasive use of smartphones, wearables, and connected devices together with significant advances in brain imaging. These new ave...
Join our webinar where we will highlight key features of the NovaSeq™ X series including technology innovations, product updates, and features of the on-board DRAGEN™ secondary a...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivit...
Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR T-cell therapies – from basic research to process development and clinical manufacturing. Discover the p...
Date: November 09, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) Over four billion prescriptions are issued each year in the US, many of which will cause adverse drug reactions and/or...
Date: June 07, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Predictive Genomics (PG) is a powerful capability to help predict disease risk and understand drug responses to improve h...
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...
With the FDA expecting to approve 10–20 cell and gene therapies (CGT) per year by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities....
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...
Twelve years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event Series...
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomic on immunology, oncology, neuroscience, ageing,...
With the FDA expecting to approve 10–20 cell and gene therapies (CGT) per year by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities....
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...
Twelve years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event Series...
To SBI2 members and sponsors, On behalf of the Society of Biomolecular Imaging and Informatics Board of Directors, I am pleased to announce the 8th annual High Content conference which will...
Join the virtual Science for Sustainability Symposia The sustainable use of raw materials in a way that conserves resources and protects the climate has been of central importance to the env...